Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Return on Assets (2024 - 2025)

Historic Return on Assets for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q4 2025 value amounting to 0.38%.

  • Neuphoria Therapeutics' Return on Assets fell 2400.0% to 0.38% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.38%, marking a year-over-year decrease of 2400.0%. This contributed to the annual value of 0.57% for FY2023, which is N/A changed from last year.
  • Neuphoria Therapeutics' Return on Assets amounted to 0.38% in Q4 2025, which was down 2400.0% from 0.56% recorded in Q3 2025.
  • In the past 5 years, Neuphoria Therapeutics' Return on Assets registered a high of 0.35% during Q1 2025, and its lowest value of 0.56% during Q3 2025.